{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:40:53Z","timestamp":1762144853797},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81000084","81070102"],"award-info":[{"award-number":["81000084","81070102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["10151008002000001"],"award-info":[{"award-number":["10151008002000001"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["20100470894"],"award-info":[{"award-number":["20100470894"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Medical Science Foundation","award":["A2011005"],"award-info":[{"award-number":["A2011005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejphar.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,3,17]],"date-time":"2012-03-17T05:29:11Z","timestamp":1331962151000},"page":"211-216","source":"Crossref","is-referenced-by-count":16,"title":["Effect of ranolazine on rat intrarenal arteries in vitro"],"prefix":"10.1016","volume":"683","author":[{"given":"Chun-Yu","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Juan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xin","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Xiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Guang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2012.03.010_bb0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00005344-199306000-00004","article-title":"Modulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: protection by ranolazine","volume":"21","author":"Allely","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2012.03.010_bb0010","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1177\/107424840400900106","article-title":"Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent","volume":"9","author":"Antzelevitch","year":"2004","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0015","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"Suppl. 4","key":"10.1016\/j.ejphar.2012.03.010_bb0020","first-page":"iv6","article-title":"Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine","volume":"92","author":"Belardinelli","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2012.03.010_bb0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0146-2806(02)70007-8","article-title":"Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor","volume":"27","author":"Chaitman","year":"2002","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2012.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/clc.4960260402","article-title":"Partial fatty acid oxidation (pFOX) inhibition: a new therapy for chronic stable angina","volume":"26","author":"Conti","year":"2003","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0045","doi-asserted-by":"crossref","first-page":"H1989","DOI":"10.1152\/ajpheart.00285.2008","article-title":"Is ranolazine an antiarrhythmic drug?","volume":"294","author":"Eckhardt","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s002100000378","article-title":"Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the cat cardiovascular system","volume":"363","author":"Letienne","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0055","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00353.2004","article-title":"Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influx","volume":"289","author":"Leung","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1388-9842(01)00240-9","volume":"4","author":"Louis","year":"2002","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(99)00190-3","article-title":"A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group","volume":"84","author":"Pepine","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0070","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1054\/jcaf.2002.129232","article-title":"Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure","volume":"8","author":"Sabbah","year":"2002","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/sj.bjp.0707492","article-title":"The cardiac persistent sodium current: an appealing therapeutic target?","volume":"153","author":"Saint","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0080","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.107.724880","volume":"116","author":"Scirica","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2012.03.010_bb0085","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00424-010-0805-5","article-title":"The endothelial saga: the past, the present, the future","volume":"459","author":"Serban","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005344-200408000-00008","article-title":"Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes","volume":"44","author":"Song","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0095","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1161\/01.STR.0000131479.08005.ca","article-title":"Raloxifene relaxes rat cerebral arteries in vitro and inhibits L-type voltage-sensitive Ca2+ channels","volume":"35","author":"Tsang","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2012.03.010_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.104.066100","article-title":"Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome","volume":"310","author":"Wu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2012.03.010_bb0105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1248\/cpb.57.1218","article-title":"Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities","volume":"57","author":"Yao","year":"2009","journal-title":"Chem. Pharm. Bull.(Tokyo)"},{"key":"10.1016\/j.ejphar.2012.03.010_bb0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/FJC.0b013e31821458e8","article-title":"Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs","volume":"57","author":"Zhao","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299912002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T02:36:44Z","timestamp":1588819004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299912002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014299912002506"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}